Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: Two-year results of the real word evidence LIBRA study

Under real-world clinical practice together with indices for assessing disease activity and the effectiveness of therapy, drug retention provides critical information on efficacy, safety, compliance and convenience of use.The aim – to obtain data on the safety of netakimab (NTK) in a population of p...

Full description

Saved in:
Bibliographic Details
Main Authors: Sh. F. Erdes, V. I. Mazurov, I. Z. Gaydukova, O. N. Anoshenkova, I. B. Vinogradova, Yu. Yu. Grabovetskaya, S. Yu. Davidian, O. E. Epifanova, N. A. Kiryukhina, L. V. Masneva, I. V. Menshikova, O. N. Mironenko, N. E. Nikulenkova, T. V. Povarova, A. N. Polyatika, R. R. Samigullina, A. E. Sizikov, I. N. Totrov, I. F. Umnova, A. L. Chudinov
Format: Article
Language:Russian
Published: IMA PRESS LLC 2025-07-01
Series:Научно-практическая ревматология
Subjects:
ankylosing spondylitis
radiological axial spondyloarthritis
netakimab
drug retention rate
adverse events
Online Access:https://rsp.mediar-press.net/rsp/article/view/3756
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://rsp.mediar-press.net/rsp/article/view/3756

Similar Items